| __timestamp | Ascendis Pharma A/S | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 13983000 | 64538000 |
| Thursday, January 1, 2015 | 8118000 | 71914000 |
| Friday, January 1, 2016 | 4606000 | 108973000 |
| Sunday, January 1, 2017 | 1530000 | 141102000 |
| Monday, January 1, 2018 | 10581000 | 251453000 |
| Tuesday, January 1, 2019 | 13375000 | 120282000 |
| Wednesday, January 1, 2020 | 6953000 | 186419000 |
| Friday, January 1, 2021 | 7778000 | 277133000 |
| Saturday, January 1, 2022 | 51174000 | 196245000 |
| Sunday, January 1, 2023 | 266718000 | 131314000 |
| Monday, January 1, 2024 | 363641000 |
Unleashing insights
In the dynamic world of biopharmaceuticals, Ascendis Pharma A/S and Ligand Pharmaceuticals Incorporated have carved distinct paths over the past decade. Ascendis Pharma, known for its innovative therapies, saw a staggering 1,800% increase in revenue from 2014 to 2023, peaking at $267 million in 2023. This growth underscores its strategic advancements and market penetration.
Conversely, Ligand Pharmaceuticals, a leader in drug discovery, experienced a more stable revenue trajectory. Despite fluctuations, Ligand's revenue reached its zenith in 2021, with a 330% increase from 2014, before settling at $131 million in 2023. This reflects its consistent market presence and adaptability.
These trends highlight the contrasting strategies and market responses of these two industry titans, offering valuable insights into the evolving landscape of biopharmaceutical revenues.
Gilead Sciences, Inc. vs Ascendis Pharma A/S: Annual Revenue Growth Compared
Revenue Insights: United Therapeutics Corporation and Ascendis Pharma A/S Performance Compared
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Catalent, Inc. vs Ascendis Pharma A/S: Annual Revenue Growth Compared
Comparing Revenue Performance: Sarepta Therapeutics, Inc. or Ascendis Pharma A/S?
Revenue Insights: Ascendis Pharma A/S and Vericel Corporation Performance Compared
Comparing Revenue Performance: Ascendis Pharma A/S or Geron Corporation?
Comparing Revenue Performance: Ascendis Pharma A/S or Celldex Therapeutics, Inc.?
Revenue Insights: Halozyme Therapeutics, Inc. and Ligand Pharmaceuticals Incorporated Performance Compared
Who Generates More Revenue? Cytokinetics, Incorporated or Ligand Pharmaceuticals Incorporated
Revenue Insights: Alkermes plc and Ligand Pharmaceuticals Incorporated Performance Compared
Annual Revenue Comparison: Ligand Pharmaceuticals Incorporated vs Evotec SE